Ostavimir is ineffective against COVID-19: in silico assessment, in vitro and retrospective study
Qi Tan, Yang Jin
doi: https://doi.org/10.1101/2020.05.15.20102392
Qi Tan
1Department of Respiratory and Critical Care Medicine, NHC Key Laboratory of Pulmonary Disease
MDYang Jin
2Wuhan Union Hospital
MDData Availability
The data used to support the findings of this study are available from the corresponding author upon request.
Posted May 20, 2020.
Ostavimir is ineffective against COVID-19: in silico assessment, in vitro and retrospective study
Qi Tan, Yang Jin
medRxiv 2020.05.15.20102392; doi: https://doi.org/10.1101/2020.05.15.20102392
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)